CHMP gives thumbs-up for We­govy use in ado­les­cents, along with nine new drug rec­om­men­da­tions

The Eu­ro­pean Med­i­cines Agency’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man Use (CHMP) rec­om­mend­ed nine drugs for ap­proval this week while al­so giv­ing thumbs up for six ex­pand­ed in­di­ca­tions, in­clud­ing No­vo Nordisk’s ap­proved obe­si­ty med­ica­tion We­govy for younger peo­ple. We­govy is al­ready ap­proved as an obe­si­ty treat­ment in the EU for adults, and the new in­di­ca­tion would al­low pre­scrip­tions for ado­les­cents aged 12 and old­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER